23andMe Is Sharing Its 5 Million Clients’ Genetic Data with Drug Giant GlaxoSmithKline

Popular genetics company 23andMe is partnering up with drug giant GlaxoSmithKline to use people’s DNA to develop medical treatments, the company announced in a blog post yesterday (July 25).

Read More

Image courtesy of: Laura Geggel

Advertisements